Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
1998-03-25
2001-02-20
Tsang, Cecilia (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S051000, C536S026800, C536S028200, C536S028540, C536S028550
Reexamination Certificate
active
06191120
ABSTRACT:
FIELD OF THE INVENTION
The present invention is directed to the use of AZT derivatives and its analogs in providing contraceptive, e.g. spermicidal, effects. In one particular embodiment, the present invention is directed to novel dual-function derivatives of AZT that exhibit spermicidal activity and maintain potent anti-HIV activity.
BACKGROUND OF THE INVENTION
The known spermicidal agents, nonoxynol-9 (N9) and gramicidin, exert their effects via a detergent-like ability to damage the sperm plasma membrane, perturb its conformation and destroy its semi-permeable nature thereby impairing the sperm motility and egg fertilizing functions (Wilborn, et al.,
Fertil Steril
1983; 39:717-719; Bourinbaiar, et al.,
Life Sci
1994; 54:PL 5-9). Because of their non-specific membrane disruptive properties, such vaginal spermicides have been shown to damage the cervicovaginal epithelium, as well, which may lead to a lower degree of protection from sexually transmitted diseases (Niruthisard, et al.,
Sex Transm Dis
1991; 18:176-179). A vaginal contraceptive that does not function with the non-specific membrane toxicity mediated by detergent-type action of the currently available vaginal contraceptives would be desirable.
In addition, the dangers of sexually-transmitted diseases have been widely recognized. However, despite the educational and preventive measures taken to date, the spread of diseases such as HIV remains a serious health problem. It would be desirable to provide a contraceptive that also provides some protection against sexually-transmitted diseases such as HIV, especially to reduce the risks for women who otherwise would be at high risk of acquiring such diseases by heterosexual transmission.
SUMMARY OF THE INVENTION
While AZT has been widely studied for its activity against HIV infection, AZT itself has not been recognized as having any contraceptive, for example spermicidal and/or sperm-immobilizing, activity. The present invention provides AZT derivatives that are useful as contraceptive agents and products and methods using them. Examples of such products include vaginal foams, creams, lotions or gels, sponges or other vaginal inserts, and condom lubricating compositions. The present invention also is directed to certain AZT derivatives that exhibit the contraceptive properties while maintaining activity against HIV.
One aspect of the present invention is directed to AZT derivatives that include 5-halo and 6-alkoxy substitution on the thymine ring of AZT and exhibit contraceptive properties.
A very important aspect of the present invention is directed to providing a contraceptive effect using novel dual-function AZT derivatives with both anti-HIV and spermicidal activity that include 5-halo and 6-alkoxy substitution on the thymine ring of AZT and substitution on the pentose ring of AZT that facilitates entry of the compound into a cell. For example, among others, the substitution on the pentose ring can be with a phosphate group, which may be further substituted with an aryl-containing group, and the aryl group itself can be further substituted. In the above aspects of the invention, the azide group on the pentose ring of AZT can be replaced with NH
2
, which optionally can be substituted, or the azide group could be replaced with halo, CN, or COOH.
A further aspect of the present invention is directed to contraceptive products that use a spermicidal AZT derivative as an active agent, and to the production of such contraceptive products.
A still further aspect of the present invention is directed to a method of contraception that includes a step of contacting sperm with a spermicidal AZT derivative, for example by means of a contraceptive product of this invention as discussed above.
REFERENCES:
patent: 4707362 (1987-11-01), Nuwayser
patent: 5069906 (1991-12-01), Cohen et al.
patent: 5595980 (1997-01-01), Brode et al.
patent: 6189998 (1994-07-01), None
patent: 9414831 (1994-07-01), None
patent: 9742962 (1997-11-01), None
D'Cruz, O. J. et al., “Aryl Phosphate Derivatives of Bromo-Methoxy-Azidothymidine Are Dual-Function Spermicides with Potent Anti-Human Immunodeficiency Virus”,Biology of Reproduction, vol. 59, pp. 503-515 (1998).
Jan, S. T., et al., “Synthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5′-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents”,Antiviral Chemistry & Chemotherapy, vol. 10, pp. 39-46 (Jul. 9, 1999).
McGuigan et al.(I), “Phosphamidates as Potent Prodrugs of Anti-HIV Nucleotidestudies in the Amino Region,”Antiviral Chemistry & Chemotherapy,7(1), 31-36 (1996).
McGuigan et al.(II), “Phosphamidate Derivatives of AZT as inhibitors of HIV: Studies on the Carboxyl Terminus,”Antiviral Chemistry & Chemotherapy,4(2), 97-101 (1993).
McGuigan et al.(III), “Aryl Phosphate Derivatives of AZT Inhibit HIV Replication in Cells Where the Nucleoside is Poorly Active,”Bioorganic & Medicinal Chemistry Letters,2(7), 701-704 (1992).
Wang et al., “In Vivo Biodistribution, Pharmacokinetic Parameters, and Brain Uptake of 5-Halo-6-methoxy (or ethoxy)-5,6-dihydro-3′-azido-3′-deoxythymidine Diastereoisomers as Potential Prodrugs of 3′-Azido-3′-deoxythymidine,”J. Medicinal Chemistry,39(4), 826-833 (Feb. 16, 1996).
Kumar et al., “Synthesis, In Vitro Biological Stability, and Anti-HIV Activity of 5-Halo-6-alkoxy (or azido)-5,6-dihydro-3′-azido-3′-deoxythymidine Diastereoisomers as Potential Produrgs to 3′-Azido-3′-deoxythymidine,”J. Medicinal Chemistry,37(25), 4297-4305 (Dec. 9, 1994).
Wiebe et al., “5-Halo-6-alkoxy-5,6-dihydro-pyrimidine Nucleosides: Antiviral Nucleosides or Nucleoside Prodrugs,”Nucleosides & Nucleotides,14(3-5), 501-505 (May-Jun.-Jul. 1995).
Bourinbaiar, A. et al., “Anti-HIV Effect of Gramicidin in Vitro: Potential for Spermicide Use”,Life Sciences,54(1):PL5-9 (1994).
Bourinbaiar, A. et al., “Comparative in vitro Study of Contraceptive Agents with Anti-HIV Activity: Gramicidin, nonoxynol-9, and gossypol”,Contraception,49(2):131-137 (Feb. 1994).
Burkman, L., “Discrimination Between Nonhyperactivated and Classical Hyperactivated Motility Patterns in Human Spermatozoa Using Computerized Analysis”,Fertility and Sterility,55(2):363-371 (Feb. 1991).
D'Cruz O. et al., “&bgr;2-Integrin (CD11b/CD18) is the Primary Adhesive Glycoprotein Complex Involved in Neutrophil-Mediatd Immune Injury to Human Sperm”,Biology of Reproduction,53(5):1118-1130 (Nov. 1995).
D'Cruz, O. et al., “Spermicidal Activity of Metallocene Complexes Containing Vanadium (IV) in Humans”,Biology of Reproduction,58(6): 1515-1526 (Jun. 1998).
Dicker, D. et al., “The Value of Repeat Hysteroscopic Evaluation in Patients with Failed in Vitro Fertilization Transfer Cycles”,Fertility and Sterility,58(4):833-835 (Oct. 1992).
Erice, A. et al., “Human Immunodeficienc Virus Type 1 Activity of an Anti-CD4 Immunoconjugate Containing Pokeweed Antivrial Protein”,Antimicrobial Agents and Chemotherapy,37(4):835-838 (Apr. 1993).
Erlandsen, S. et al., “Membrane Fixation for High-Resolution Low-Voltage SEM: Studies onGiardia,Rat Spermatozoa, and Mouse Macrophages”,Scanning,11(4) 169-175 (Jul./Aug. 1989).
McGuigan, C. et al., “Intracellular Delivery of Bioactive AZT Nucleotides by Aryl Phosphate Derivatives of AZT”,J. Med. Chem.,36(8):1048-1052 (Apr. 16, 1993).
McGuigan, C. et al., “Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite”,J. Med. Chem.,39(8):1748-1753 (Apr. 12, 1996).
McGuigan, C. et al., “Phosphoramidate Derivatives of d4T with Improved Anti-HIV Efficacy Retain Full Activity in Thymidine Kinase-Deficient Cells”,Bioorganic & Medicinal Chemistry Letters,6(10):1183-1186 (May 21, 1996).
Niruthisard, S. et al., “The Effects of Frequent Nonoxynol-q Use on the Vaginal and Cervical Mucosa”,Sexually Transmitted Diseases,18(3):176-179 (Jul.-Sep. 1991).
Soffel, M. et al., “Improved Preservation of Rat Epididymal Sperm for High-Resolution Low-Voltage Scanning Electron Microscopy
D'Cruz Osmond
Uckun Fatih M.
Venkatachalam Taracad
Crane L. E.
Merchant & Gould P.C.
Tsang Cecilia
Wayne Hughes Institute
LandOfFree
Spermicidally active... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spermicidally active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spermicidally active... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2586238